论文信息 - 945P Adjuvant lenvatinib in combination with TACE for hepatocellular carcinoma patients with high risk of postoperative relapse (LANCE): Updated results from a multi-center prospective cohort study - 字舞流文

945P Adjuvant lenvatinib in combination with TACE for hepatocellular carcinoma patients with high risk of postoperative relapse (LANCE): Updated results from a multi-center prospective cohort study

L. Qin | X. Xu | L. Lu | B. Xiang | C-D. Lu | J. Chen | Y-Y. Zeng | Z-Y. Huang | X. Li | T. Wen | T. Zhang | T. Zhang | T. Zhang